ID LINK NAME STRUCTURE CAS CLOGP CLOGS MW THERAPEUTIC AREA
FDBD00069 Flunisolide Responsive image
3385-03-3
2.627 -3.014 434.498 For the maintenance treatment of asthma as a prophylactic therapy.
FDBD00070 Baclofen Responsive image
1134-47-0
1.873 -2.288 213.661 For the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
FDBD00071 Amphetamine Responsive image
300-62-9
1.942 -2.090 135.206 For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
FDBD00072 Pentagastrin Responsive image
5534-95-2
3.825 -7.198 767.891 Used as a diagnostic aid for evaluation of gastric acid secretory function.
FDBD00073 Nicotine Responsive image
1954/11/5
1.885 -2.011 162.232 For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.
FDBD00074 Cevimeline Responsive image
107233-08-9
1.837 -1.477 199.313 For the treatment of symptoms of dry mouth in patients with Sjögren's Syndrome.
FDBD00075 Lorazepam Responsive image
846-49-1
3.915 -5.064 321.158 For the management of anxiety disorders, and for treatment of status epilepticus.
FDBD00076 Esmolol Responsive image
81147-92-4
2.720 -3.568 295.374 For the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Also used in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention.
FDBD00077 Bortezomib Responsive image
179324-69-7
0.125 -3.515 384.237 For treatment of multiple myeloma in patients who have not been successfully treated with at least two previous therapies.
FDBD00078 Ethchlorvynol Responsive image
113-18-8
1.638 -0.911 144.599 Used for short-term hypnotic therapy in the management of insomnia for periods of up to one week in duration; however, this medication generally has been replaced by other sedative-hypnotic agents.
2911 , 292